ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003

BACKGROUND: ND630 is believed to be a new therapy pharmacologic molecule in targeting the expression of ACACA and regulating the lipid metabolism. However, the function of ND630 in prostate cancer remains unknown. KIF18B, as an oncogene, plays a vital role in prostate cancer progression. circKIF18B_...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yu-Peng, Zheng, Wen-Cai, Huang, Qi, Huang, Xu-Yun, Lin, Fei, Ke, Zhi-Bin, You, Qi, Zheng, Qing-Shui, Wei, Yong, Xue, Xue-Yi, Xu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694902/
http://dx.doi.org/10.1186/s12967-023-04760-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694902/
http://dx.doi.org/10.1186/s12967-023-04760-w

Ejemplares similares